Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease of lung parenchymal scarring that is triggered by ...

Is vaping cannabis less harmful to your health than smoking it? Many people seem to think so. However, two studies conducted ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Attempts to understand the complex pathobiology of the mediators of ALI have led to improvements in clinical outcomes, particularly in terms of low tidal volume ventilation. [53] Ventilation with ...

Two recent studies from The Institute suggest that cannabis vapour may have adverse effects on lung cellsIs vaping cannabis ...

Panelists discuss how idiopathic pulmonary fibrosis (IPF), a progressive and often fatal interstitial lung disease, presents ...

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis ...

But several strands of evidence are calling this approach into question. The pulmonary epithelium not only provides a barrier between the outside environment and internal parenchyma but also ...

A surge in clinical trials investigating potential idiopathic pulmonary fibrosis therapies offers patients new hope, ...

The discovery that lung epithelium responds to cigarette smoke with the UPR, followed by antioxidant and cytokine gene expression, has implications for monitoring patients with COPD. It suggests ...

NeoGenomics has commercially launched the c-MET Companion Diagnostic (CDx) for use in non-small cell lung cancer (NSCLC).

Rein Therapeutics has initiated the randomised RENEW Phase II trial of its Caveolin-1-related peptide, LTI-03, targeting ...